1. Home
  2. IROQ vs PRLD Comparison

IROQ vs PRLD Comparison

Compare IROQ & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IF Bancorp Inc.

IROQ

IF Bancorp Inc.

N/A

Current Price

$26.25

Market Cap

84.4M

Sector

Finance

ML Signal

N/A

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$1.68

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IROQ
PRLD
Founded
1883
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.4M
69.1M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
IROQ
PRLD
Price
$26.25
$1.68
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
3.0K
445.3K
Earning Date
01-29-2026
11-12-2025
Dividend Yield
1.52%
N/A
EPS Growth
157.16
N/A
EPS
1.60
N/A
Revenue
$27,979,000.00
$10,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.42
N/A
Revenue Growth
24.68
250.00
52 Week Low
$22.04
$0.61
52 Week High
$26.50
$4.22

Technical Indicators

Market Signals
Indicator
IROQ
PRLD
Relative Strength Index (RSI) 61.09 52.65
Support Level $26.05 $1.30
Resistance Level $26.46 $1.56
Average True Range (ATR) 0.07 0.17
MACD 0.01 0.01
Stochastic Oscillator 72.22 83.92

Price Performance

Historical Comparison
IROQ
PRLD

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: